Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,977
Total Claims
$900K
Drug Cost
627
Beneficiaries
$1,435
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 16,767 Hospitalist providers
-69%
Opioid rate vs peers
0.9% vs 3.0% avg
+236%
Cost per patient vs peers
$1,435 vs $427 avg
+85%
Brand preference vs peers
9.7% vs 5.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.9%
Opioid Rate
102
Opioid Claims
$440
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,049 claims · $687K
Generic: 9,745 claims · $204K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 109 | $110K |
| Dapagliflozin Propanediol | 47 | $41K |
| Insulin Glargine,hum.Rec.Anlog | 53 | $27K |
| Semaglutide | 19 | $26K |
| Empagliflozin | 17 | $25K |
| Fluticasone Propion/Salmeterol | 125 | $21K |
| Insulin Detemir | 30 | $20K |
| Dulaglutide | 20 | $20K |
| Linagliptin | 22 | $17K |
| Insulin Nph Hum/Reg Insulin Hm | 44 | $15K |
| Insulin Detemir | 18 | $14K |
| Fluticasone Propion/Salmeterol | 58 | $13K |
| Albuterol Sulfate | 353 | $12K |
| Galcanezumab-Gnlm | 13 | $9,919 |
| Fluticasone/Umeclidin/Vilanter | 12 | $8,604 |
Prescribing Profile
Patient Profile
69
Avg Age
62%
Female
2.55
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About